Table 1.
Demographic and symptom severity information of included subjects.
| All sites | Leuven | NYU | USM | Yale | |
|---|---|---|---|---|---|
| N | 185 | 25 | 101 | 25 | 34 |
| TDC | 95 | 14 | 51 | 11 | 19 |
| ASD | 90 | 11 | 50 | 14 | 15 |
| Autism/Aspergers/PDD-NOS | 85/17/14 | 11/0/0 | 38/8/4 | 13/0/1 | 3/4/8 |
| Age | 13.2 (3.2) | 14.1 (1.4) | 12.0 (3.0) | 16.3 (2.4) | 12.5 (3.0) |
| TDC | 13.2 (3.1) | 14.5 (1.6) | 12.5 (3.1) | 15.8 (2.6) | 12.3 (2.9) |
| ASD | 13.1 (3.3) | 13.6 (1.0) | 11.5 (2.9) | 16.7 (2.2) | 12.8 (3.4) |
| SRS | 56.4 (43.4) | 49.8 (45.0) | 57.5 (41.8) | 62.0 (46.6) | 52.0 (43.1) |
| TDC | 19.1 (14.7) | 17.6 (13.6) | 22.4 (13.6) | 14.6 (12.8) | 20.4 (21.3) |
| ASD | 93.0 (28.4) | 91.0 (36.0) | 91.9 (29.6) | 99.3 (22.2) | 95.7 (21.1) |
Mean and standard deviation (italics) are provided for each continuous measure. N, number; ASD, autism spectrum disorder; TDC, typically-developing children; SRS, Social Responsiveness Scale; PDD-NOS, pervasive developmental disorder - not otherwise specified; NYU, New York University; USM, Utah School of Medicine.